Basic Information
Basic information for SNHG14-265-33aa
Peptide Name SNHG14-265-33aa
Genome Position chr15:25110101-25110199[+]
Species Human
Peptide Sequence MFTGPTSSWNFEQTDSLVAHLICLAVNVGQYLD
Peptide Length 33
Unique No (SNHG14-208-33aa-2,SNHG14-216-33aa-1,SNHG14-299-33aa-2)
Grand Average of Hydropathicity 0.2758
Relative Molecular Mass 4234.69
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000659236;SNHG14-265
Transcript Length 2150
Coding Ability 0.4293
DNA Sequence Corresponding to Peptide ATGTTCACCGGGCCAACATCTTCTTGGAACTTTGAGCAAACTGATAGTCTGGTTGCACATTTGATTTGTCTGGCAGTAAATGTTGGACAGTATTTGGAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :